Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in IDYA — IDEAYA Biosciences, Inc.

CIK 1423053 MIAMI, FL
Back to IDYA Full portfolio

Position in IDYA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$22,637,607
-$10,527,294 QoQ
Shares Held
679,400
-29.2% QoQ
Ownership
0.773%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
20 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in IDYA Over Time

Shares Held

Position Value (USD)

Derivatives in IDYA

reported options exposure · as of Mar 31, 2026
CallValue
$506,464
CallShares
15,200
PutValue
$2,615,620
PutShares
78,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,784,241,435 across 374 Biotechnology names. IDYA ranks #56 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INSM
INSMED Inc
 2,182,571 $356,894,009
2 ONC
BeOne Medicines Ltd.
 1,032,298 $306,561,536
3 BMRN
Biomarin Pharmaceutical Inc
 4,512,634 $254,918,694
4 JAZZ
Jazz Pharmaceuticals plc
 1,259,444 $238,097,887
5 MDGL
Madrigal Pharmaceuticals, Inc.
 453,843 $237,573,195
6 BBIO
BridgeBio Pharma, Inc.
 3,173,940 $235,696,783
7 TERN
Terns Pharmaceuticals, Inc.
 3,218,810 $169,695,662
8 PTGX
Protagonist Therapeutics, Inc
 1,551,900 $163,570,260

All Filings in IDYA

Export CSV
49 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $506,464 15,200
2026-03-31 $22,637,607 679,400
2026-03-31 $2,615,620 78,500
2025-12-31 $1,265,262 36,600
2025-12-31 $653,373 18,900
2025-12-31 $33,164,901 959,355
2025-09-30 $443,523 16,300
2025-09-30 $35,835,324 1,316,991
2025-06-30 $38,380,480 1,825,903
2025-06-30 $603,274 28,700
2025-06-30 $441,420 21,000
2025-03-31 $24,653,210 1,505,080
2025-03-31 $499,590 30,500
2025-03-31 $871,416 53,200
2024-12-31 $47,206,530 1,836,830
2024-12-31 $619,370 24,100
2024-12-31 $788,990 30,700
2024-09-30 $449,856 14,200
2024-09-30 $33,339,429 1,052,381
2024-09-30 $212,256 6,700
2024-06-30 $298,435 8,500
2024-06-30 $51,939,030 1,479,323
2024-06-30 $277,369 7,900
2024-03-31 $62,811,850 1,431,446
2024-03-31 $109,700 2,500
2024-03-31 $320,324 7,300
2023-12-31 $128,088 3,600
2023-12-31 $138,762 3,900
2023-12-31 $58,468,364 1,643,293
2023-09-30 $20,102,797 745,100
2023-09-30 $256,310 9,500
2023-09-30 $159,182 5,900
2023-06-30 $27,105,581 1,153,429
2023-06-30 $227,950 9,700
2023-06-30 $190,350 8,100
2023-03-31 $13,882,622 1,011,116
2023-03-31 $76,888 5,600
2022-12-31 $16,114,227 886,859
2022-12-31 $7,268 400
2022-12-31 $3,461,385 190,500
2022-09-30 $3,273,448 219,400
2022-09-30 $18,719,944 1,254,688
2022-06-30 $9,950,407 721,044
2022-06-30 $3,325,800 241,000
2022-03-31 $1,186,140 106,000
2022-03-31 $4,035,024 360,592
2021-12-31 $406,608 17,200
2020-12-31 $396,704 28,336
2020-06-30 $3,524,150 248,005

Report a Problem

Category
Description
Email (optional, for follow-up)